{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:48:09Z","timestamp":1788601689818,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01757"],"award-info":[{"award-number":["PI18\/01757"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00223-020-00787-z","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T13:02:42Z","timestamp":1610802162000},"page":"423-438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Bone Disease in CKD in Children"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0029-8252","authenticated-orcid":false,"given":"Fernando","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"D\u00edaz-Anad\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor A","family":"Ord\u00f3\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,16]]},"reference":[{"key":"787_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:1\u201359","journal-title":"Kidney Int Suppl"},{"key":"787_CR2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00467-011-1939-1","volume":"27","author":"J Harambat","year":"2012","unstructured":"Harambat J, van Stralen KJ, Kim JJ, Tizard EJ (2012) Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27:363\u2013373","journal-title":"Pediatr Nephrol"},{"key":"787_CR3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/ckj\/sfw047","volume":"9","author":"F Becherucci","year":"2016","unstructured":"Becherucci F, Roperto RM, Materassi M, Romagnani P (2016) Chronic kidney disease in children. Clin Kidney J 9:583\u2013591","journal-title":"Clin Kidney J"},{"key":"787_CR4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrneph.2011.139","volume":"7","author":"CP Schmitt","year":"2011","unstructured":"Schmitt CP, Mehls O (2011) Mineral and bone disorders in children with chronic kidney disease. Nat Rev Nephrol 7:624\u2013634","journal-title":"Nat Rev Nephrol"},{"key":"787_CR5","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrneph.2011.116","volume":"7","author":"R Shroff","year":"2011","unstructured":"Shroff R, Weaver DJ Jr, Mitsnefes MM (2011) Cardiovascular complications in children with chronic kidney disease. Nat Rev Nephrol 7:642\u2013649","journal-title":"Nat Rev Nephrol"},{"key":"787_CR6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/ndt\/gft275","volume":"29","author":"P Delanaye","year":"2014","unstructured":"Delanaye P, Souberbielle JC, Lafage-Proust MH, Jean G, Cavalier E (2014) Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts. Nephrol Dial Transplant 29:997\u20131004","journal-title":"Nephrol Dial Transplant"},{"key":"787_CR7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruyere O et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391\u2013420","journal-title":"Osteoporos Int"},{"key":"787_CR8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11914-017-0365-0","volume":"15","author":"MR Hanudel","year":"2017","unstructured":"Hanudel MR, Salusky IB (2017) Treatment of pediatric chronic kidney disease-mineral and bone disorder. Curr Osteoporos Rep 15:198\u2013206","journal-title":"Curr Osteoporos Rep"},{"key":"787_CR9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0272-6386(97)90086-X","volume":"30","author":"DM Kates","year":"1997","unstructured":"Kates DM, Sherrard DJ, Andress DL (1997) Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. Am J Kidney Dis 30:809\u2013813","journal-title":"Am J Kidney Dis"},{"key":"787_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","volume":"14","author":"SM Moe","year":"2007","unstructured":"Moe SM, Drueke T, Lameire N, Eknoyan G (2007) Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis 14:3\u201312","journal-title":"Adv Chronic Kidney Dis"},{"key":"787_CR11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11255-019-02290-3","volume":"52","author":"A Figurek","year":"2020","unstructured":"Figurek A, Rroji M, Spasovski G (2020) Sclerostin: a new biomarker of CKD-MBD. Int Urol Nephrol 52:107\u2013113","journal-title":"Int Urol Nephrol"},{"key":"787_CR12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00198-014-2954-4","volume":"26","author":"Y Nagata","year":"2015","unstructured":"Nagata Y, Inaba M, Imanishi Y et al (2015) Increased undercarboxylated osteocalcin\/intact osteocalcin ratio in patients undergoing hemodialysis. Osteoporos Int 26:1053\u20131061","journal-title":"Osteoporos Int"},{"key":"787_CR13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS et al (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112:683\u2013692","journal-title":"J Clin Invest"},{"key":"787_CR14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T et al (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770\u2013774","journal-title":"Nature"},{"key":"787_CR15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1744-9987.2005.00292.x","volume":"9","author":"K Miyamoto","year":"2005","unstructured":"Miyamoto K, Ito M, Kuwahata M, Kato S, Segawa H (2005) Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. Ther Apher Dial 9:331\u2013335","journal-title":"Ther Apher Dial"},{"key":"787_CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y et al (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429\u2013435","journal-title":"J Bone Miner Res"},{"key":"787_CR17","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V et al (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003\u20134008","journal-title":"J Clin Invest"},{"key":"787_CR18","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","volume":"27","author":"Y Sabbagh","year":"2012","unstructured":"Sabbagh Y, Graciolli FG, O\u2019Brien S et al (2012) Repression of osteocyte Wnt\/betacatenin signaling is an early event in the progression of renal osteodystrophy. J Bone Miner Res 27:1757\u20131772","journal-title":"J Bone Miner Res"},{"key":"787_CR19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","volume":"8","author":"S Pelletier","year":"2013","unstructured":"Pelletier S, Dubourg L, Carlier MC et al (2013) The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol 8:819\u2013823","journal-title":"Clin J Am Soc Nephrol"},{"key":"787_CR20","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2009-1576","volume":"95","author":"J Bacchetta","year":"2010","unstructured":"Bacchetta J, Dubourg L, Harambat J et al (2010) The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease. J Clin Endocrinol Metab 95:1741\u20131748","journal-title":"J Clin Endocrinol Metab"},{"issue":"78","key":"787_CR21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ki.2010.107","volume":"2010","author":"M van Husen","year":"2010","unstructured":"van Husen M, Fischer AK, Lehnhardt A et al (2010) Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. Kidney Int 2010(78):200\u2013206","journal-title":"Kidney Int"},{"key":"787_CR22","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1093\/ndt\/gfs109","volume":"27","author":"MD Sinha","year":"2012","unstructured":"Sinha MD, Turner C, Dalton RN et al (2012) Investigating FGF-23 concentrations and its relationship with declining renal function in paediatric patients with predialysis CKD stages 3-5. Nephrol Dial Transplant 27:4361\u20134368","journal-title":"Nephrol Dial Transplant"},{"key":"787_CR23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2215\/CJN.05840513","volume":"9","author":"AA Portale","year":"2014","unstructured":"Portale AA, Wolf M, J\u00fcppner H et al (2014) Disordered FGF23 and mineral metabolism in children with CKD. Clin J Am Soc Nephrol 9:344\u2013353","journal-title":"Clin J Am Soc Nephrol"},{"key":"787_CR24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.ajkd.2019.07.022","volume":"75","author":"T Isakova","year":"2020","unstructured":"Isakova T, Cai X, Lee J et al (2020) Longitudinal evolution of markers of mineral metabolism in patients with CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 75:235\u2013244","journal-title":"Am J Kidney Dis"},{"key":"787_CR25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","volume":"82","author":"M Wolf","year":"2012","unstructured":"Wolf M (2012) Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int 82:737\u2013747","journal-title":"Kidney Int"},{"key":"787_CR26","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00467-014-2919-z","volume":"30","author":"NM Khouzam","year":"2015","unstructured":"Khouzam NM, Wesseling-Perry K, Salusky IB (2015) The role of bone in CKD-mediated mineral and vascular disease. Pediatr Nephrol 30:1379\u20131388","journal-title":"Pediatr Nephrol"},{"key":"787_CR27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1681\/ASN.2009040427","volume":"21","author":"R Canalejo","year":"2010","unstructured":"Canalejo R, Canalejo A, Martinez-Moreno JM et al (2010) FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol 21:1125\u20131135","journal-title":"J Am Soc Nephrol"},{"key":"787_CR28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","volume":"6","author":"J Cunningham","year":"2011","unstructured":"Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6:913\u2013921","journal-title":"Clin J Am Soc Nephrol"},{"key":"787_CR29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0272-6386(95)90541-3","volume":"25","author":"F Llach","year":"1995","unstructured":"Llach F (1995) Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited. Am J Kidney Dis 25:663\u2013679","journal-title":"Am J Kidney Dis"},{"key":"787_CR30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/ki.1994.312","volume":"46","author":"CH Hsu","year":"1994","unstructured":"Hsu CH, Patel SR, Young EW, Vanholder R (1994) The biological action of calcitriol in renal failure. Kidney Int 46:605\u2013612","journal-title":"Kidney Int"},{"key":"787_CR31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.ki.5002287","volume":"74","author":"WG Goodman","year":"2007","unstructured":"Goodman WG, Quarles LD (2007) Development and progression of secondary hyperparathyroidism in chronic kidney disease: Lessons from molecular genetics. Kidney Int 74:276\u2013288","journal-title":"Kidney Int"},{"key":"787_CR32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1385\/EP:14:1:61","volume":"14","author":"M Martin-Salvago","year":"2003","unstructured":"Martin-Salvago M, Villar-Rodriguez JL, Palma-Alvarez A, Beato-Moreno A, Galera-Davidson H (2003) Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure. Endocr Pathol 14:61\u201370","journal-title":"Endocr Pathol"},{"issue":"Pt 5","key":"787_CR33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1258\/acb.2012.012004","volume":"49","author":"R Lewis","year":"2012","unstructured":"Lewis R (2012) Mineral and bone disorders in chronic kidney disease: new insights into mechanism and management. Ann Clin Biochem 49(Pt 5):432\u2013440","journal-title":"Ann Clin Biochem"},{"key":"787_CR34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41581-019-0161-4","volume":"15","author":"J Drube","year":"2019","unstructured":"Drube J, Wan M, Bonthuis M et al (2019) Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol 15:577\u2013589","journal-title":"Nat Rev Nephrol"},{"key":"787_CR35","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM200009283431304","volume":"343","author":"D Haffner","year":"2000","unstructured":"Haffner D, Schaefer F, Nissel R, Wuhl E, Tonshoff B, Mehls O (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med 343:923\u2013930","journal-title":"N Engl J Med"},{"key":"787_CR36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fped.2019.00278","volume":"7","author":"R Behnisch","year":"2019","unstructured":"Behnisch R, Kirchner M, Anarat A et al (2019) Determinants of statural growth in European children with chronic kidney disease: Findings from the cardiovascular comorbidity in children with chronic kidney disease (4C) study. Front Pediatr 7:278","journal-title":"Front Pediatr"},{"key":"787_CR37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3747\/pdi.2012.00126","volume":"32","author":"F Schaefer","year":"2012","unstructured":"Schaefer F, Borzych-Duzalka D, Azocar M et al (2012) Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: Insights from the international pediatric peritoneal dialysis network registry. Perit Dial Int 32:399\u2013409","journal-title":"Perit Dial Int"},{"key":"787_CR38","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00467-013-2604-7","volume":"28","author":"D Franke","year":"2013","unstructured":"Franke D, Alakan H, Pavicic L et al (2013) Birth parameters and parental height predict growth outcome in children with chronic kidney disease. Pediatr Nephrol 28:2335\u20132341","journal-title":"Pediatr Nephrol"},{"key":"787_CR39","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00467-016-3432-3","volume":"32","author":"D Haffner","year":"2017","unstructured":"Haffner D, Zivicnjak M (2017) Pubertal development in children with chronic kidney disease. Pediatr Nephrol 32:949\u2013964","journal-title":"Pediatr Nephrol"},{"key":"787_CR40","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00467-020-04559-7","volume":"35","author":"HS Kim","year":"2020","unstructured":"Kim HS, Ng DK, Matheson MB et al (2020) Delayed menarche in girls with chronic kidney disease and the association with short stature. Pediatr Nephrol 35:1471\u20131475","journal-title":"Pediatr Nephrol"},{"key":"787_CR41","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00467-013-2502-z","volume":"28","author":"D Franke","year":"2013","unstructured":"Franke D, Winkel S, Gellermann J et al (2013) Growth and maturation improvement in children on renal replacement therapy over the past 20\u00a0years. Pediatr Nephrol 28:2043\u20132051","journal-title":"Pediatr Nephrol"},{"key":"787_CR42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/TP.0b013e3182247bd5","volume":"92","author":"J Tainio","year":"2011","unstructured":"Tainio J, Qvist E, Vehmas R et al (2011) Pubertal development is normal in adolescents after renal transplantation in childhood. Transplantation 92:404\u2013409","journal-title":"Transplantation"},{"key":"787_CR43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2215\/CJN.02180314","volume":"10","author":"D Franke","year":"2015","unstructured":"Franke D, Thomas L, Steffens R et al (2015) Patterns of growth after kidney transplantation among children with ESRD. Clin J Am Soc Nephrol 10:127\u2013134","journal-title":"Clin J Am Soc Nephrol"},{"key":"787_CR44","doi-asserted-by":"crossref","first-page":"dgaa267","DOI":"10.1210\/clinem\/dgaa267","volume":"105","author":"A Ewert","year":"2020","unstructured":"Ewert A, Leifheit-Nestler M, Hohenfellner K et al (2020) Bone and mineral metabolism in children with nephropathic cystinosis compared with other CKD entities. J Clin Endocrinol Metab 105:dgaa267","journal-title":"J Clin Endocrinol Metab"},{"key":"787_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04623-2","author":"L Rees","year":"2020","unstructured":"Rees L, Shaw V, Qizalbash L et al (2020) Delivery of a nutritional prescription by enteral tube feeding in children with chronic kidney disease stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-020-04623-2","journal-title":"Pediatr Nephrol"},{"key":"787_CR46","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ki.2010.316","volume":"78","author":"D Borzych","year":"2010","unstructured":"Borzych D, Rees L, Ha IS et al (2010) The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int 78:1295\u20131304","journal-title":"Kidney Int"},{"key":"787_CR47","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1046\/j.1523-1755.2002.00616.x","volume":"62","author":"M Daschner","year":"2002","unstructured":"Daschner M, Philippin B, Nguyen T et al (2002) Circulating inhibitor of gonadotropin releasing hormone secretion by hypothalamic neurons in uremia. Kidney Int 62:1582\u20131590","journal-title":"Kidney Int"},{"key":"787_CR48","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/ndt\/gfu003","volume":"29","author":"D Wiezel","year":"2014","unstructured":"Wiezel D, Assadi MH, Landau D et al (2014) Impaired renal growth hormone JAK\/STAT5 signaling in chronic kidney disease. Nephrol Dial Transplant 29:791\u2013799","journal-title":"Nephrol Dial Transplant"},{"key":"787_CR49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00467-005-1821-0","volume":"20","author":"B Tonshoff","year":"2005","unstructured":"Tonshoff B, Kiepe D, Ciarmatori S (2005) Growth hormone\/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol 20:279\u2013289","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 1","key":"787_CR50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000229761","volume":"72","author":"RC Olney","year":"2009","unstructured":"Olney RC (2009) Mechanisms of impaired growth: Effect of steroids on bone and cartilage. Horm Res 72(Suppl 1):30\u201335","journal-title":"Horm Res"},{"key":"787_CR51","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1210\/er.2002-0033","volume":"24","author":"BCJ van der Eerden","year":"2003","unstructured":"van der Eerden BCJ, Karperien M, Wit JM (2003) Systemic and local regulation of the growth plate. Endocr Rev 24:782\u2013801","journal-title":"Endocr Rev"},{"key":"787_CR52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00467-018-4160-7","volume":"35","author":"A Fern\u00e1ndez-Iglesias","year":"2020","unstructured":"Fern\u00e1ndez-Iglesias A, L\u00f3pez JM, Santos F (2020) Growth plate alterations in chronic kidney disease. Pediatr Nephrol 35:367\u2013374","journal-title":"Pediatr Nephrol"},{"key":"787_CR53","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00467-004-1652-4","volume":"20","author":"F Santos","year":"2005","unstructured":"Santos F, Carbajo-P\u00e9rez E, Rodr\u00edguez J et al (2005) Alterations of the growth plate in chronic renal failure. Pediatr Nephrol 20:330\u2013334","journal-title":"Pediatr Nephrol"},{"key":"787_CR54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1113\/jphysiol.1989.sp017676","volume":"414","author":"EB Hunziker","year":"1989","unstructured":"Hunziker EB, Schenk RK (1989) Physiological mechanisms adopted by chondrocytes in regulating longitudinal bone growth in rats. J. Physiol 414:55\u201371","journal-title":"J. Physiol"},{"key":"787_CR55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nature11940","volume":"495","author":"KL Cooper","year":"2013","unstructured":"Cooper KL, Oh S, Sung Y, Dasari RR, Kirschner MW, Tabin CJ (2013) Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions. Nature 495:375\u2013378","journal-title":"Nature"},{"key":"787_CR56","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/oxfordjournals.ndt.a027089","volume":"11","author":"P Ure\u00f1a","year":"1996","unstructured":"Ure\u00f1a P, Ferreira A, Morieux C, Dr\u00fceke T, de Vernejoul MC (1996) PTH\/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats. Nephrol Dial Transplant 11:2008\u20132016","journal-title":"Nephrol Dial Transplant"},{"key":"787_CR57","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2013.196","volume":"84","author":"A Troib","year":"2013","unstructured":"Troib A, Landau D, Kachko L, Rabkin R, Segev Y (2013) Epiphyseal growth plate growth hormone receptor signaling is decreased in chronic kidney disease-related growth retardation. Kidney Int 84:940\u2013949","journal-title":"Kidney Int"},{"key":"787_CR58","doi-asserted-by":"crossref","first-page":"F57","DOI":"10.1152\/ajprenal.00051.2015","volume":"309","author":"D Claramunt","year":"2015","unstructured":"Claramunt D, Gil-Pe\u00f1a H, Fuente R et al (2015) Chronic kidney disease induced by adenine: a suitable model of growth retardation in uremia. Am J Physiol Renal Physiol 309:F57\u2013F62","journal-title":"Am J Physiol Renal Physiol"},{"key":"787_CR59","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/ndt\/gfv373","volume":"31","author":"A Troib","year":"2016","unstructured":"Troib A, Guterman M, Rabkin R, Landau D, Segev Y (2016) Endurance exercise and growth hormone improve bone formation in young and growth-retarded chronic kidney disease rats. Nephrol Dial Transplant 31:1270\u20131279","journal-title":"Nephrol Dial Transplant"},{"key":"787_CR60","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.3390\/ijms21124519","volume":"21","author":"\u00c1 Fern\u00e1ndez-Iglesias","year":"2020","unstructured":"Fern\u00e1ndez-Iglesias \u00c1, Fuente R, Gil-Pe\u00f1a H et al (2020) Innovative three-dimensional microscopic analysis of uremic growth plate discloses alterations in the process of chondrocyte hypertrophy: effects of growth hormone treatment. Int J Mol Sci 21:4519","journal-title":"Int J Mol Sci"},{"key":"787_CR61","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/sj.ki.5001949","volume":"70","author":"I Molinos","year":"2006","unstructured":"Molinos I, Santos F, Carbajo-Perez E et al (2006) Catch-up growth follows an abnormal pattern in experimental renal insufficiency and growth hormone treatment normalizes it. Kidney Int 70:1955\u20131961","journal-title":"Kidney Int"},{"key":"787_CR62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/er.2015-1026","volume":"37","author":"SC Wong","year":"2016","unstructured":"Wong SC, Dobie R, Altowati MA, Werther GA, Farquharson C, Ahmed SF (2016) Growth and the growth hormone-insulin like growth factor 1 axis in children with chronic inflammation: current evidence, gaps in knowledge, and future directions. Endocr Rev 37:62\u2013110","journal-title":"Endocr Rev"},{"key":"787_CR63","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fped.2020.00399","volume":"8","author":"D Haffner","year":"2020","unstructured":"Haffner D (2020) Strategies for optimizing growth in children with chronic kidney disease. Front Pediatr 8:399","journal-title":"Front Pediatr"},{"key":"787_CR64","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","volume":"34","author":"E Lurbe","year":"2016","unstructured":"Lurbe E, Agabiti-Rosei E, Cruickshank JK et al (2016) European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34:1887\u20131920","journal-title":"J Hypertens"},{"key":"787_CR65","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/ndt\/gfp565","volume":"25","author":"M Fischbach","year":"2010","unstructured":"Fischbach M, Terzic J, Menouer S, Dheu C, Seuge L, Zalosczic A (2010) Daily on line haemodiafiltration promotes catch-up growth in children on chronic dialysis. Nephrol Dial Transplant 25:867\u2013873","journal-title":"Nephrol Dial Transplant"},{"key":"787_CR66","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1681\/ASN.2018100990","volume":"30","author":"R Shroff","year":"2019","unstructured":"Shroff R, Smith C, Ranchin B et al (2019) Effects of hemodiafiltration versus conventional hemodialysis in children with ESKD: the HDF, heart and height study. J Am Soc Nephrol 30:678\u2013691","journal-title":"J Am Soc Nephrol"},{"key":"787_CR67","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00467-019-04426-0","volume":"35","author":"V Shaw","year":"2020","unstructured":"Shaw V, Polderman N, Renken-Terhaerdt J et al (2020) Energy and protein requirements for children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol 35:519\u2013531","journal-title":"Pediatr Nephrol"},{"key":"787_CR68","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00467-019-04399-0","volume":"35","author":"D Haffner","year":"2020","unstructured":"Haffner D, Leifheit-Nestler M (2020) Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levels. Pediatr Nephrol 35:485\u2013491","journal-title":"Pediatr Nephrol"},{"key":"787_CR69","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00467-019-04400-w","volume":"35","author":"J Bacchetta","year":"2020","unstructured":"Bacchetta J (2020) Treatment of hyperphosphatemia: the dangers of high PTH levels. Pediatr Nephrol 35:493\u2013500","journal-title":"Pediatr Nephrol"},{"key":"787_CR70","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/ndt\/gfx080","volume":"32","author":"R Shroff","year":"2017","unstructured":"Shroff R, Wan M, Nagler EV et al (2017) Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysis. Nephrol Dial Transplant 32:1114\u20131127","journal-title":"Nephrol Dial Transplant"},{"key":"787_CR71","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ndt\/gfx065","volume":"32","author":"R Shroff","year":"2017","unstructured":"Shroff R, Wan M, Nagler EV et al (2017) Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2-5 and on dialysis. Nephrol Dial Transplant 32:1098\u20131113","journal-title":"Nephrol Dial Transplant"},{"key":"787_CR72","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00467-009-1387-3","volume":"25","author":"RN Fine","year":"2010","unstructured":"Fine RN, Martz K, Stablein D (2010) What have 20 years of data from the North American Pediatric Renal Transplant Cooperative Study taught us about growth following renal transplantation in infants, children, and adolescents with end-stage renal disease? Pediatr Nephrol 25:739\u2013746","journal-title":"Pediatr Nephrol"},{"key":"787_CR73","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1432-2277.2011.01400.x","volume":"25","author":"B Klare","year":"2012","unstructured":"Klare B, Montoya CR, Fischer DC, Stangl MJ, Haffner D (2012) Normal adult height after steroid-withdrawal within 6\u00a0months of pediatric kidney transplantation: a 20\u00a0years single center experience. Transpl Int 25:276\u2013282","journal-title":"Transpl Int"},{"key":"787_CR74","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s00467-011-1934-6","volume":"26","author":"A Delucchi","year":"2011","unstructured":"Delucchi A, Valenzuela M, Lillo AM et al (2011) Early steroid withdrawal in pediatric renal transplant: five years of follow-up. Pediatr Nephrol 26:2235\u20132244","journal-title":"Pediatr Nephrol"},{"key":"787_CR75","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113:S1\u2013S130","journal-title":"Kidney Int Suppl"},{"key":"787_CR76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","volume":"21","author":"G Klaus","year":"2006","unstructured":"Klaus G, Watson A, Edefonti A et al (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21:151\u2013159","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 3","key":"787_CR77","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation, Foundation National Kidney (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(Suppl 3):S1\u2013S201","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"787_CR78","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1053\/ajkd.2001.20748","volume":"37","author":"JD Kopple","year":"2001","unstructured":"Kopple JD (2001) National kidney foundation K\/DOQI clinical practice guidelines for nutrition in chronic renal failure. 37. Am J Kidney Dis 37(Suppl 2):S66\u2013S70","journal-title":"Am J Kidney Dis"},{"key":"787_CR79","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.jrn.2016.01.009","volume":"26","author":"L Gutekunst","year":"2016","unstructured":"Gutekunst L (2016) An update on phosphate binders: a dietitian\u2019s perspective. J Ren Nutr 26:209\u2013218","journal-title":"J Ren Nutr"},{"key":"787_CR80","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00467-020-04516-4","volume":"35","author":"BA Warady","year":"2020","unstructured":"Warady BA, Ng E, Bloss L, Mo M, Schaefer F, Bacchetta J (2020) Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis. Pediatr Nephrol 35:1679\u20131697","journal-title":"Pediatr Nephrol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00787-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-020-00787-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00787-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T19:19:37Z","timestamp":1618600777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-020-00787-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,16]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["787"],"URL":"https:\/\/doi.org\/10.1007\/s00223-020-00787-z","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,16]]},"assertion":[{"value":"10 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}